Nanoparticle|Based Vaccines Against Respiratory Viruses

Nanoparticle-Based Vaccines Against Respiratory Viruses - Frontiers

This short review provides an overview of the advantages associated with the use of nanoparticles as vaccine delivery platforms to immunize against respiratory ...

Nanoparticle-Based Vaccines Against Respiratory Viruses - PubMed

A new generation of vaccines based on nanoparticles has shown great potential to address most of the limitations of conventional and subunit vaccines.

Nanoparticle-Based Vaccines Against Respiratory Viruses - PMC

Engineered nanoparticles have demonstrated their potential as vaccine delivery platforms. They can be envisaged as both antigen nanocarriers and adjuvants. In ...

An intranasal nanoparticle STING agonist protects against ... - Nature

Three classes of interventions comprise the modern arsenal of responses against respiratory viruses: vaccines, antibodies, and antivirals.

Revolutionizing polymer-based nanoparticle-linked vaccines for ...

Currently, vaccination remains as the most cost-effective strategy to combat against respiratory infections. Conventional vaccines typically ...

Design and Preclinical Evaluation of a Nanoparticle Vaccine against ...

RSV attachment and entry is governed by two virus-encoded surface glycoproteins: the fusion protein F and the attachment protein G. F is a trimeric class I ...

An epitope-specific chemically defined nanoparticle vaccine for ...

Respiratory syncytial virus (RSV) can cause severe respiratory disease in humans, particularly in infants and the elderly.

Viral nanoparticle vaccines against S100A9 reduce lung tumor ...

We demonstrate the effectiveness of the S100A9 vaccine candidates in preventing tumor seeding within the lungs and outgrowth of metastatic disease.

Recent Advances in Inhaled Nanoformulations of Vaccines and ...

2). In a study by Sawaengsak et al., a chitosan nanoparticle was used as the vehicle for intranasal vaccine of HA-split influenza virus [82].

Vaccines based on virus-like nano-particles for use against Middle ...

Recent advances in virus-like nanoparticles against Middle East respiratory syndrome-related coronavirus (MERS-CoV) can initiate vaccine ...

Contribution of Nanotechnologies to Vaccine Development and ...

We evaluated those which could be beneficial for respiratory disease-based viruses; those which already have contributed, such as lipid ...

Full article: Nanoparticle Vaccines Against Respiratory Syncytial Virus

Vaccination is a cost-effective, widely implemented strategy for fighting infectious diseases. It has aided in the successful control of detrimental infections ...

(PDF) Nanoparticle-Based Vaccines Against Respiratory Viruses

Expert Opinion: Previous and current preclinical and clinical studies suggest that recombinant VLP and nanoparticle vaccines are expected to be ...

Nanoparticle-Based Vaccines against Zoonotic Viruses: A Review

Nanoparticle vaccines have been shown to significantly decrease lung virus loads and protect against SARS-CoV-2 infection in animals [51].

Emerging Advances of Nanotechnology in Drug and Vaccine ... - MDPI

These nano-vaccines can mimic specific mucosal immune responses by providing a distinct formulation, size, and antigen exposition similar to respiratory viruses ...

A respiratory syncytial virus (RSV) F protein nanoparticle vaccine ...

This self-assembling nanoparticle vaccine induced stronger neutralizing antibody responses than pre-F trimers in both mice and nonhuman primates.

Immunizations for Respiratory Viruses Prevention - CDC

For most people that means getting a current flu and COVID-19 vaccine. · Everyone ages 75 and older should get a respiratory syncytial virus (RSV) ...

Effectiveness of Vaccines and Monoclonal Antibodies Against ...

Several immunization products are currently being developed against respiratory syncytial virus (RSV) for ... based on polymerase chain ...

Nanoparticle Vaccines Against Respiratory Syncytial Virus

Particle size can also be modified to target specific antigen-presenting cells in order to induce specific types of effector T-cell responses. Numerous ...

Respiratory syncytial virus prevention within reach: the vaccine and ...

An mRNA vaccine (mRNA-1345) encodes stabilised RSV pre-F and uses the same lipid nanoparticle formulation as for the SARS-CoV-2 vaccine SpikeVax ...